USofCare’s Resources to Understand the Federal Regulatory Landscape of Artificial Intelligence in Health Care

As stakeholders decide how to best take advantage of artificial intelligence (AI) within the health care sector, policymakers have the responsibility to ensure that patient experiences are at the forefront while working to prevent and minimize systemic inequities perpetuated by this technology. 

At United States of Care (United States of Care (USofCare), we are driven to build a better health care system through listening to people’s needs from the health care system and centering them within the policymaking process. Recently, we released a report detailing  insights from our preliminary work listening to patients’ thoughts and experiences related to the use of AI in health care. 

At the federal level, the regulation of the Department of Health & Human Services (HHS) is broadly tasked with regulating and investigating how AI is used in health care contexts. The Biden Administration, through its October 2022 Executive Blueprint for an AI Bill of Rights and its March 2024 Office of Management and Budget (OMB) Policy Memorandum, outlined its vision for the design and deployment of AI across a variety of sectors, with a particular emphasis on using AI to lead to innovation while instituting consumer protections and safeguards. 

It is essential that policies regulating the use of AI in health care prioritize the concerns, needs, and experiences of its end users: people and communities. As Congress and state legislatures begin to take action, USofCare created a glossary of key terms that people may encounter when discussing AI in health care, as well as an issue brief and corresponding fact sheet that capture a snapshot of the federal regulatory landscape thus far.

Artificial Intelligence in Health Care: